Edwardsiella tarda Native Valve Infective Endocarditis in a Young and Non-Immunocompromised Host: A Case Report.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
09 Oct 2021
Historique:
entrez: 9 10 2021
pubmed: 10 10 2021
medline: 13 10 2021
Statut: epublish

Résumé

BACKGROUND Infective endocarditis (IE) is an infectious disease that occurs in valves, centered on the endocardium and ventricular septal defects. It is a serious disease that is easily misdiagnosed and has a high mortality rate if left untreated. Edwardsiella tarda is an extremely rare cause of IE, especially in young and non-immunocompromised hosts. CASE REPORT A woman in her 20s presented to our hospital with fever of unknown cause and liver dysfunction. She was admitted to the Department of Gastroenterological Medicine owing to suspicion of gastrointestinal infection. Gastrointestinal examination, including contrast-enhanced computer tomography and endoscopic ultrasonography, was performed; however, there were no significant findings. Liver dysfunction improved spontaneously, but her fever did not improve with antibiotic treatment. Transthoracic echocardiography was performed on day 9 of hospitalization because E. tarda was detected in a blood culture test, revealing vegetation at the mitral valve. Asymptomatic cerebral infarction was shown by brain magnetic resonance imaging, and mitral valvuloplasty was performed on day 14. After surgery, transthoracic echocardiography was performed on day 22, showing no vegetation or mitral regurgitation. However, postoperative transesophageal ultrasonography performed on day 29 revealed severe mitral regurgitation. Redo mitral valvuloplasty was performed on day 38. She clinically improved and was discharged on day 67. CONCLUSIONS This is the first case in which E. tarda was diagnosed as the causative agent of IE on a native valve in a young and non-immunocompromised host. Aggressive source control resulted in a good clinical outcome.

Identifiants

pubmed: 34625525
pii: 932387
doi: 10.12659/AJCR.932387
pmc: PMC8515497
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e932387

Références

Int J Clin Pract. 2005 Aug;59(8):917-21
pubmed: 16033613
J La State Med Soc. 2009 Mar-Apr;161(2):103-6
pubmed: 19489391
Eur Heart J. 2019 Oct 14;40(39):3222-3232
pubmed: 31504413
Case Rep Infect Dis. 2016;2016:1082160
pubmed: 26885418
Pediatr Transplant. 2008 Mar;12(2):238-41
pubmed: 18086238
Indian J Med Microbiol. 2012 Jul-Sep;30(3):352-4
pubmed: 22885207
Ann Intern Med. 2007 Dec 18;147(12):829-35
pubmed: 18087053
Clin Infect Dis. 1993 Oct;17(4):742-8
pubmed: 8268359
Circ J. 2013;77(6):1558-64
pubmed: 23524445
Antimicrob Agents Chemother. 2001 Aug;45(8):2245-55
pubmed: 11451681
Clin Infect Dis. 1997 Oct;25(4):918-9
pubmed: 9356809

Auteurs

Masamichi Koike (M)

Department of Cardiology, Teine Keijinkai Hospital, Sapporo, Hokkaido, Japan.

Takahiro Doi (T)

Department of Cardiology, Teine Keijinkai Hospital, Sapporo, Hokkaido, Japan.

Yutaka Iba (Y)

Department of Cardiovascular Surgery, Teine Keijinkai Hospital, Sapporo, Hokkaido, Japan.

Satoshi Yuda (S)

Department of Cardiology, Teine Keijinkai Hospital, Sapporo, Hokkaido, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH